Deciphering sulfoglycolipids of Mycobacterium tuberculosis

Emilie Layre1, Diane Cala-De Paepe1, Gérald Larrouy-Maumus1

  • 1CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale); 205 route de Narbonne, F-31077, Toulouse, France; UPS, Université de Toulouse, UPS; IPBS; F-31077 Toulouse, France.

Summary

Sulfoglycolipids (SGLs) are crucial for Mycobacterium tuberculosis virulence. This study reveals novel SGL structures and intermediates, offering new insights into their biosynthesis and potential drug targets.